Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies
- PMID: 18058231
- DOI: 10.1007/s10985-007-9070-0
Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies
Abstract
Absolute risk is the chance that a person with given risk factors and free of the disease of interest at age a will be diagnosed with that disease in the interval (a, a + tau]. Absolute risk is sometimes called cumulative incidence. Absolute risk is a "crude" risk because it is reduced by the chance that the person will die of competing causes of death before developing the disease of interest. Cohort studies admit flexibility in modeling absolute risk, either by allowing covariates to affect the cause-specific relative hazards or to affect the absolute risk itself. An advantage of cause-specific relative risk models is that various data sources can be used to fit the required components. For example, case-control data can be used to estimate relative risk and attributable risk, and these can be combined with registry data on age-specific composite hazard rates for the disease of interest and with national data on competing hazards of mortality to estimate absolute risk. Family-based designs, such as the kin-cohort design and collections of pedigrees with multiple affected individuals can be used to estimate the genotype-specific hazard of disease. Such analyses must be adjusted for ascertainment, and failure to take into account residual familial risk, such as might be induced by unmeasured genetic variants or by unmeasured behavioral or environmental exposures that are correlated within families, can lead to overestimates of mutation-specific absolute risk in the general population.
Similar articles
-
Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study.Genet Epidemiol. 2001 Sep;21(2):123-38. doi: 10.1002/gepi.1022. Genet Epidemiol. 2001. PMID: 11507721
-
Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries.Stat Med. 2019 Dec 20;38(29):5528-5546. doi: 10.1002/sim.8381. Epub 2019 Oct 28. Stat Med. 2019. PMID: 31657494
-
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.Oncologist. 1996;1(5):326-330. Oncologist. 1996. PMID: 10388011
-
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions.J Clin Epidemiol. 2013 Jun;66(6):648-53. doi: 10.1016/j.jclinepi.2012.09.017. Epub 2013 Feb 14. J Clin Epidemiol. 2013. PMID: 23415868 Review.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty.Am J Hum Genet. 2009 Dec;85(6):786-800. doi: 10.1016/j.ajhg.2009.10.017. Am J Hum Genet. 2009. PMID: 19931039 Free PMC article.
-
Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer.J Clin Oncol. 2013 Jan 1;31(1):119-27. doi: 10.1200/JCO.2012.41.8996. Epub 2012 Nov 19. J Clin Oncol. 2013. PMID: 23169509 Free PMC article.
-
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.Int J Cancer. 2023 May 15;152(10):2069-2080. doi: 10.1002/ijc.34444. Epub 2023 Feb 1. Int J Cancer. 2023. PMID: 36694401 Free PMC article.
-
Estimation of genotype relative risks from pedigree data by retrospective likelihoods.Genet Epidemiol. 2010 May;34(4):287-98. doi: 10.1002/gepi.20460. Genet Epidemiol. 2010. PMID: 20039378 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical